Biocon Biologics, Viatris get EC nod to Biosimilar Insulin Aspart Kixelle Ruchika Sharma12 Feb 2021 3:43 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has announced that Kixelle, a biosimilar Insulin Aspart co-developed with Viatris...
Biocon Biologics inks pact to provide cancer biosimilars to 30 countries in Africa, Asia Ruchika Sharma5 Feb 2021 3:09 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has recently signed an agreement with the Clinton Health Access Initiative (CHAI) to...
Biocon Biologics appoints Professor Peter Piot as Independent Director Ruchika Sharma22 Jan 2021 1:12 PM ISTBengaluru: Biocon Biologics Ltd. has recently announced that the company has inducted Professor Peter Piot to its Board as an Independent Director....
Biocon subsidiary approves primary equity investment of Rs 555 crore by Abu Dhabi-based ADQ Ruchika Sharma8 Jan 2021 12:30 PM ISTBengaluru: Biocon Ltd has recently announced that the Board of its subsidiary Biocon Biologics Ltd has approved a primary equity investment...
USFDA informs Biocon Biologics, Mylan about biosimilar Avastin deferred action Ruchika Sharma26 Dec 2020 11:52 AM ISTNew Delhi: Biotechnology major Biocon on Friday said its arm, Biocon Biologics, and Mylan have been informed by the US health regulator of a deferred...
Biocon Biologics, CSSC collaborate for Mission 10 cents Ruchika Sharma16 Dec 2020 1:21 PM ISTBiocon Biologics' Mission 10 Cents to Unlock Affordable Access to Quality Insulins
Biocon Biologics approves Rs 1,125 crore investment from Goldman Sachs Ruchika Sharma9 Nov 2020 1:00 PM ISTAs per the terms of the proposed agreement, Goldman Sachs will be issued Optionally Convertable Debentures at a post money equity valuation of USD...
Biocon arm, Mylan launch diabetes drug Semglee in US Medical Dialogues Bureau1 Sept 2020 10:45 AM IST"The commercialization of our insulin glargine in the US represents another milestone achievement for Biocon in making insulin-based therapy...
Tata Capital Growth Fund to invest Rs 225 crore in Biocon Biologics Ruchika Sharma1 Aug 2020 11:42 AM ISTPost the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics, the biotechnology major added.
Biocon Biologics, Voluntis collaborate for digital therapeutics for diabetics patients Ruchika Sharma22 July 2020 1:22 PM ISTNew Delhi: Biocon Biologics on Tuesday announced a global collaboration agreement with Voluntis to develop and distribute digital therapeutics...
Biocon to invest over Rs 1493 crore capex for current fiscal Ruchika Sharma4 July 2020 1:40 PM ISTThe capex will be funded through a combination of contribution from internal accruals, debt raise as well as an additional private equity investment...
Biocon Biologics gets DCGI nod for use of CytoSorb in critical COVID-19 cases Hina Zahid28 May 2020 2:13 PM ISTBiopharmaceutical company Biocon on Wednesday announced that its subsidiary Biocon Biologics has received the Drugs Controller General of India's...
